Another study showed that HO-1 might show anti-inflammatory activity in the mouse model of acute experimental colitis by regulating the balance between Th17 and Treg cells, thus providing a new therapeutic target for inflammatory bowel disease (Zhang et al., 2014). Here, HMOX1 is linked to colitis.